CN101085062A - 一种治疗帕金森病的药物及其制备方法 - Google Patents
一种治疗帕金森病的药物及其制备方法 Download PDFInfo
- Publication number
- CN101085062A CN101085062A CNA2007100160871A CN200710016087A CN101085062A CN 101085062 A CN101085062 A CN 101085062A CN A2007100160871 A CNA2007100160871 A CN A2007100160871A CN 200710016087 A CN200710016087 A CN 200710016087A CN 101085062 A CN101085062 A CN 101085062A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- fried liquid
- disease
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 208000018737 Parkinson disease Diseases 0.000 title abstract description 8
- 229940079593 drug Drugs 0.000 title description 4
- 238000000034 method Methods 0.000 title description 4
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 6
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 6
- 241001165494 Rhodiola Species 0.000 claims abstract description 5
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 11
- 241000005787 Cistanche Species 0.000 claims description 5
- 241000756943 Codonopsis Species 0.000 claims description 5
- 241000218628 Ginkgo Species 0.000 claims description 5
- 241000237636 Pheretima Species 0.000 claims description 5
- 241000131808 Scolopendra Species 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005267 amalgamation Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 241000258920 Chilopoda Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 abstract 1
- 241000336315 Cistanche salsa Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 210000001364 upper extremity Anatomy 0.000 description 5
- 210000003141 lower extremity Anatomy 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000008921 facial expression Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000005021 gait Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000007659 motor function Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 201000002882 Agraphia Diseases 0.000 description 1
- 241000195622 Astasia Species 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000648 anti-parkinson Effects 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940052764 dopaminergic anti-parkinson drug mao b inhibitors Drugs 0.000 description 1
- 210000005064 dopaminergic neuron Anatomy 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010058319 dysgraphia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 208000008136 parkinson disease 10 Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000000862 serotonergic effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000003523 substantia nigra Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100160871A CN101085062B (zh) | 2007-06-16 | 2007-06-16 | 一种治疗帕金森病的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100160871A CN101085062B (zh) | 2007-06-16 | 2007-06-16 | 一种治疗帕金森病的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101085062A true CN101085062A (zh) | 2007-12-12 |
CN101085062B CN101085062B (zh) | 2010-09-01 |
Family
ID=38936346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100160871A Expired - Fee Related CN101085062B (zh) | 2007-06-16 | 2007-06-16 | 一种治疗帕金森病的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101085062B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147460A (zh) * | 2014-09-02 | 2014-11-19 | 杭州金培科技有限公司 | 一种治疗帕金森病的中药制剂及其制备方法 |
CN104587052A (zh) * | 2015-02-13 | 2015-05-06 | 陈红 | 一种用于帕金森病治疗的中药组合物及其用途 |
CN106309637A (zh) * | 2015-06-17 | 2017-01-11 | 上海张江中药现代制剂技术工程研究中心 | 治疗帕金森病的中药组合物及其制备方法 |
-
2007
- 2007-06-16 CN CN2007100160871A patent/CN101085062B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147460A (zh) * | 2014-09-02 | 2014-11-19 | 杭州金培科技有限公司 | 一种治疗帕金森病的中药制剂及其制备方法 |
CN104587052A (zh) * | 2015-02-13 | 2015-05-06 | 陈红 | 一种用于帕金森病治疗的中药组合物及其用途 |
CN106309637A (zh) * | 2015-06-17 | 2017-01-11 | 上海张江中药现代制剂技术工程研究中心 | 治疗帕金森病的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101085062B (zh) | 2010-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101757569A (zh) | 一种治疗脑血栓、脑梗塞的中药组合物及其制备方法 | |
CN102228525B (zh) | 治疗心脑血管瘀阻的中药 | |
CN101732616B (zh) | 一种治疗脑溢血的中药组合物及其制备方法 | |
CN101134083A (zh) | 用于治疗糖尿病及其并发症的中草药胶囊及其制备方法 | |
CN101085062B (zh) | 一种治疗帕金森病的药物及其制备方法 | |
CN102319346B (zh) | 一种治疗高血压的口服液 | |
CN101721608B (zh) | 用于治疗心脏病的中草药丸 | |
CN106309533A (zh) | 中药组合物及其应用 | |
CN103007159B (zh) | 校正胰岛功能的中药制剂 | |
CN104524058A (zh) | 一种治疗脑震荡的中药制剂及制备方法 | |
CN103610949A (zh) | 一种有效治疗高血压的中药制剂 | |
CN105687798A (zh) | 一种治疗中风的中药外用制剂及其制备方法 | |
CN102048956A (zh) | 一种药酒 | |
CN103768408B (zh) | 一种防治肛肠疾病术后疼痛的药物 | |
CN101185704B (zh) | 一种治疗口疮的散剂药物 | |
CN104127797B (zh) | 一种治疗颅脑外伤后失语的中药制剂及其制备方法 | |
CN102526541A (zh) | 一种有效调理女性更年期综合症的组合物 | |
CN102698004A (zh) | 缓解抑郁症的石菖蒲中药制剂及制备方法 | |
CN107669887A (zh) | 一种改善气虚体质的药物或保健食品组合物及其制备方法 | |
CN103585372B (zh) | 一种治疗脑性瘫痪的中药制剂 | |
CN102335203A (zh) | 微型汤剂 | |
CN105688170A (zh) | 一种治疗中风的外用中药组合物、其制剂及其制备方法 | |
CN101623460B (zh) | 一种治疗风湿痹痛的药物及其制备方法 | |
CN103655915A (zh) | 一种用于治疗风湿骨病的胶囊 | |
CN105362596A (zh) | 一种治疗肺气肿的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO UNIVERSITY Free format text: FORMER OWNER: LIANG ZIJUN Effective date: 20080718 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080718 Address after: 308, Ningxia Road, Shandong, Qingdao Province, China: 266071 Applicant after: Qingdao University Address before: North port city of Qingdao province Shandong four weft Road No. 2 23 households in a post encoding: 266012 Applicant before: Liang Zijun |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100901 Termination date: 20130616 |